- Home
- ICUI vs FORM Comparison
ICUI vs FORM Comparison
Compare ICUI & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- FORM
- Stock Information
- Founded
- ICUI 1984
- FORM 1993
- Country
- ICUI United States
- FORM United States
- Employees
- ICUI N/A
- FORM N/A
- Industry
- ICUI Medical/Dental Instruments
- FORM Semiconductors
- Sector
- ICUI Health Care
- FORM Technology
- Exchange
- ICUI Nasdaq
- FORM Nasdaq
- Market Cap
- ICUI 3.2B
- FORM 3.0B
- IPO Year
- ICUI 1992
- FORM N/A
- Fundamental
- Price
- ICUI $140.16
- FORM $52.25
- Analyst Decision
- ICUI Buy
- FORM Buy
- Analyst Count
- ICUI 6
- FORM 8
- Target Price
- ICUI $183.60
- FORM $48.57
- AVG Volume (30 Days)
- ICUI 290.1K
- FORM 1.5M
- Earning Date
- ICUI 11-06-2025
- FORM 10-29-2025
- Dividend Yield
- ICUI N/A
- FORM N/A
- EPS Growth
- ICUI N/A
- FORM N/A
- EPS
- ICUI N/A
- FORM 0.53
- Revenue
- ICUI $2,320,363,000.00
- FORM $759,313,000.00
- Revenue This Year
- ICUI N/A
- FORM $3.95
- Revenue Next Year
- ICUI N/A
- FORM $10.24
- P/E Ratio
- ICUI N/A
- FORM $98.84
- Revenue Growth
- ICUI N/A
- FORM 2.29
- 52 Week Low
- ICUI $107.00
- FORM $22.58
- 52 Week High
- ICUI $196.26
- FORM $61.10
- Technical
- Relative Strength Index (RSI)
- ICUI 73.86
- FORM 59.27
- Support Level
- ICUI $116.21
- FORM $51.41
- Resistance Level
- ICUI $120.60
- FORM $55.70
- Average True Range (ATR)
- ICUI 4.88
- FORM 2.91
- MACD
- ICUI 1.92
- FORM 0.42
- Stochastic Oscillator
- ICUI 69.73
- FORM 54.99
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.